{"disease":{"id":"malignant-primary-brain-tumors","name":"malignant primary brain tumors"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04396717","title":"Safety Study of Pritumumab in Brain Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Nascent Biotech","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}